Last reviewed · How we verify
Diabetes mellitus type 2 at increased risk of cardiovascular disease
Approved treatments
- Inpefa · Lexicon Pharms Inc
Inpefa works by blocking the sodium/glucose cotransporter 2 in the kidneys, reducing glucose reabsorption and lowering blood sugar levels.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Diabetes mellitus type 2 at increased risk of cardiovascular disease patent landscape — cliff calendar, originator estates, attackable patents
- Diabetes mellitus type 2 at increased risk of cardiovascular disease treatment landscape brief
- Diabetes mellitus type 2 at increased risk of cardiovascular disease treatment updates RSS
Frequently asked questions about Diabetes mellitus type 2 at increased risk of cardiovascular disease
What drugs treat Diabetes mellitus type 2 at increased risk of cardiovascular disease?
Tracked treatments include Inpefa.
What is the treatment for Diabetes mellitus type 2 at increased risk of cardiovascular disease?
Standard treatment for Diabetes mellitus type 2 at increased risk of cardiovascular disease includes Inpefa. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Diabetes mellitus type 2 at increased risk of cardiovascular disease patent cliff · Diabetes mellitus type 2 at increased risk of cardiovascular disease CI report
- Treatment: Inpefa · Lexicon Pharms Inc
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing